ClinicalTrials.Veeva

Menu

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

L

Lei Li

Status

Unknown

Conditions

Driving Mutations
Epithelial Ovarian Cancer
Epithelial Ovarian Tumor of Borderline Malignancy
Progression-free Survival

Study type

Observational

Funder types

Other

Identifiers

NCT03742388
EOC-BORDERLINE

Details and patient eligibility

About

Epithelial ovarian carcinomatous and borderline components sometimes appeared in one patient. This study aims to analyze the genomic patterns of the carcinomatous and borderline components in the ovarian epithelial tissues. These tissues will be collected from paraffin section by microdissection to distinguish normal, carcinomatous and borderline tissues.

Enrollment

40 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed primary epithelial ovarian borderline tumor with cancer
  • Signed an approved informed consents
  • Feasible for sampling

Exclusion criteria

  • Not meeting all of the inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Lei Li, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems